| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/28/2006 | EP1674095A1 Phototherapy compositions |
| 06/28/2006 | EP1673353A1 Transition state structure and inhibitors of thymidine phosphorylases |
| 06/28/2006 | EP1673338A1 Fatty acid compounds, preparation and uses thereof |
| 06/28/2006 | EP1673085A2 C-met modulators and methods of use |
| 06/28/2006 | EP1673076A1 Breast cancer treatment regimen |
| 06/28/2006 | EP1594488B1 Stabilized pharmaceutical compositions of safingol and methods of using the same |
| 06/28/2006 | EP1562920B1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 06/28/2006 | EP1492561B1 Methods for treating mammary gland disorders |
| 06/28/2006 | EP1377591B1 Tumour inhibiting gallium compounds |
| 06/28/2006 | EP1372694B1 Liposome targeting of matrix metalloproteinase inhibitors |
| 06/28/2006 | EP1372636B1 Metronomic dosing of taxanes for inhibiting tumor growth |
| 06/28/2006 | EP1272653B1 Methods for ansamitocin production |
| 06/28/2006 | EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 06/28/2006 | EP1268405B1 Treatment of tumors with rar alpha selective retinoid compounds in combination with other anti-tumor agents |
| 06/28/2006 | EP1255536B1 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2006 | EP1218031B1 Pharmaceutical composition comprising an antigen |
| 06/28/2006 | EP1214452B1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 06/28/2006 | EP1159756B1 Compounds for the treatment of cancer |
| 06/28/2006 | EP1157034B1 Process for production of diphtheria toxin |
| 06/28/2006 | EP1156789B9 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 06/28/2006 | EP1154767B9 Substituted stilbene compounds with vascular damaging activity |
| 06/28/2006 | EP1142905B1 Novel depsipeptide compound |
| 06/28/2006 | EP1140212B1 The use of radium-223 to target calcified tissues for pain palliation and therapy of bone cancer |
| 06/28/2006 | EP1011638A4 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 06/28/2006 | EP0797676B9 Recombinant adenoviral vector and methods of use |
| 06/28/2006 | EP0787138B1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 06/28/2006 | CN1795208A Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders |
| 06/28/2006 | CN1795206A Galectin 9-inducing factors |
| 06/28/2006 | CN1795195A Pyridopyrazines and the use thereof as kinase inhibitors |
| 06/28/2006 | CN1795194A Pyridopyrazines and the use thereof as kinase inhibitors |
| 06/28/2006 | CN1795183A Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
| 06/28/2006 | CN1795179A Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 06/28/2006 | CN1795175A Acetylene derivatives as inhibitors of histone deacetylase |
| 06/28/2006 | CN1795005A Medicine health-care usage of globefish I collagen extration and preparing process thereof |
| 06/28/2006 | CN1795002A Rock flour, especially dolomite-based medicament, for the treatment of cancer diseases |
| 06/28/2006 | CN1795001A Medicament for internal application, in particular against cancerous diseases |
| 06/28/2006 | CN1794996A Macrocyclic quinazoline derivatives as antiproliferative agents |
| 06/28/2006 | CN1794991A Pharmaceutical composition containing histone deacetylase inhibitor |
| 06/28/2006 | CN1793360A siRNA sequence of inhibiting PCNA gene expressing and application thereof |
| 06/28/2006 | CN1793343A Tumourolytic anticancer recombined adenovirus with tumour target direction and idioctonia |
| 06/28/2006 | CN1793179A Optimizing fusion protein containing VEGF recerver segment and medical application thereof |
| 06/28/2006 | CN1793174A Anti-cancer active protein of syngnathus |
| 06/28/2006 | CN1793173A Process for preparing agglutinin of loranthyl |
| 06/28/2006 | CN1793168A Process for preparing anticencer active protein of thick muzzle syngnathus |
| 06/28/2006 | CN1793165A Process for producing asparagus saponin |
| 06/28/2006 | CN1793154A 3,5-di-0-(4-chlorobenzoyl)-2-deoxide-D-erythro-furan glucoside and preparation process thereof |
| 06/28/2006 | CN1793148A Poly-substituted flavan zothia dizoline kind compound and preparation process and use thereof |
| 06/28/2006 | CN1793145A 7-bit substituted comptothecine kind compound and pharmaceutical use thereof |
| 06/28/2006 | CN1793136A Process for producing kuh-seng total flavone and flavone salt |
| 06/28/2006 | CN1793135A Process for producing kuh-seng total flavone and flavone salt by kuh-seng |
| 06/28/2006 | CN1793134A Process for separating purifying actived tea polyphenols |
| 06/28/2006 | CN1793104A Process for extracting high purity alpha-linolenic acid from pepper category and medicine application thereof |
| 06/28/2006 | CN1793087A Total triterpenoid extract fine thim asterium sponge and its preparation process and application thereof |
| 06/28/2006 | CN1792380A Digestive tract stent with anti-cancer medicinal particles |
| 06/28/2006 | CN1792375A Traditional Chinese medicine prescription for treating lung cancer |
| 06/28/2006 | CN1792367A Method for controlling quality of injection for treating tumor |
| 06/28/2006 | CN1261593C Use of IC 53 gene and its related product in diagnosing and treating colon cancer and reagent box for diagnosing colon canter |
| 06/28/2006 | CN1261580C Plasmid of recombinant immunotoxin IP 10-DT 390 aimed at activating Th1 cell, and its preparing method and use |
| 06/28/2006 | CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof |
| 06/28/2006 | CN1261452C Sugar conjugated material CHB extracted from serum of turtle or/and tortoise, preparation process and application in pharmacy thereof |
| 06/28/2006 | CN1261448C Method for extracting antineoplastic components in ganoderma lucidum triterpene |
| 06/28/2006 | CN1261431C 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 06/28/2006 | CN1261429C Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 06/28/2006 | CN1261165C Preparation for prophylaxis of restenosis |
| 06/28/2006 | CN1261163C Stabilization of macrolides |
| 06/28/2006 | CN1261162C Process for preparing aqueous extracts of plants and extracts obtained |
| 06/28/2006 | CN1261142C Use of a serra repens extract for the production of a medicament to treat prostate cancer |
| 06/28/2006 | CN1261127C Medicament for treating cancer |
| 06/28/2006 | CN1261103C Anticancer microbial drug material, its preparing method and usage |
| 06/28/2006 | CN1261100C Medicinal composition containing triphenyl-boroxin for boron neutron catching treatment |
| 06/28/2006 | CN1261097C Nisoldipine capsule composition |
| 06/28/2006 | CN1261096C Compound preparation of reveratrol and application |
| 06/27/2006 | USRE39151 Process for the preparation and purification of thiol-containing maytansinoids |
| 06/27/2006 | US7067679 Therapy for breast cancer; plant extracts |
| 06/27/2006 | US7067661 useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis |
| 06/27/2006 | US7067653 Porphyrin Based neuton capture agents for cancer therapy |
| 06/27/2006 | US7067649 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis. |
| 06/27/2006 | US7067635 For use in diagnostic methods, immunotherapy, gene therapy and as vaccines |
| 06/27/2006 | US7067632 VP22 proteins and uses thereof |
| 06/27/2006 | US7067619 Integrin-binding peptides |
| 06/27/2006 | US7067554 Method for the synthesis of compounds of formula I and their uses thereof |
| 06/27/2006 | US7067544 a high purity epothilone from Sorangium cellulosum; anticarcinogenic, antitumor agents |
| 06/27/2006 | US7067543 Anthranilic acid amides and pharmaceutical use thereof |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067537 Anticancer, antitumor agents |
| 06/27/2006 | US7067532 Substituted quinolines as antitumor agents |
| 06/27/2006 | US7067531 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol |
| 06/27/2006 | US7067522 anticarcinogenic, antitumor, antiproliferative agents; focal adhesion kinase (FAK) and cyclin-dependent kinase (CDK) enzyme inhibitors |
| 06/27/2006 | US7067521 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7pyridinyl-imidazo[1,2-alpha]pyrimidin-5(1H)-one derivatives |
| 06/27/2006 | US7067519 human orexin receptor antagonists; analgesics, antidiabetic agents; sleep apnea, insomnia |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/27/2006 | US7067511 1,1'-((Propane-1,3-diyl)dioxy)bis((11aS)-7-methoxy-2 -methy lidene-1,2,3,11-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazep in-5-one) derivatives; viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease |
| 06/27/2006 | US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
| 06/27/2006 | US7067508 Diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition |
| 06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |